Diaceutics PLC

DB:7DC Stock Report

Market Cap: €117.5m

Diaceutics Management

Management criteria checks 2/4

Diaceutics' CEO is Ryan Keeling, appointed in Jan 2024, has a tenure of less than a year. total yearly compensation is £282.49K, comprised of 95.2% salary and 4.8% bonuses, including company stock and options. directly owns 3.54% of the company’s shares, worth €4.16M. The average tenure of the management team and the board of directors is 0.8 years and 0.1 years respectively.

Key information

Ryan Keeling

Chief executive officer

UK£282.5k

Total compensation

CEO salary percentage95.2%
CEO tenureless than a year
CEO ownership3.5%
Management average tenureless than a year
Board average tenureless than a year

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ryan Keeling's remuneration changed compared to Diaceutics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-UK£3m

Mar 31 2024n/an/a

-UK£2m

Dec 31 2023UK£282kUK£269k

-UK£2m

Sep 30 2023n/an/a

-UK£870k

Jun 30 2023n/an/a

UK£6k

Mar 31 2023n/an/a

UK£365k

Dec 31 2022UK£334kUK£252k

UK£724k

Sep 30 2022n/an/a

UK£427k

Jun 30 2022n/an/a

UK£129k

Mar 31 2022n/an/a

UK£345k

Dec 31 2021UK£231kUK£220k

UK£561k

Sep 30 2021n/an/a

-UK£294k

Jun 30 2021n/an/a

-UK£1m

Mar 31 2021n/an/a

-UK£443k

Dec 31 2020UK£225kUK£215k

UK£263k

Sep 30 2020n/an/a

UK£2m

Jun 30 2020n/an/a

UK£3m

Mar 31 2020n/an/a

UK£2m

Dec 31 2019UK£236kUK£175k

UK£398k

Sep 30 2019n/an/a

UK£124k

Jun 30 2019n/an/a

-UK£151k

Mar 31 2019n/an/a

UK£241k

Dec 31 2018UK£78kn/a

UK£632k

Compensation vs Market: Ryan's total compensation ($USD354.75K) is about average for companies of similar size in the German market ($USD472.15K).

Compensation vs Earnings: Ryan's compensation has been consistent with company performance over the past year.

CEO

Ryan Keeling (42 yo)

less than a year

Tenure

UK£282,494

Compensation

Mr. Ryan Keeling serves as Executive Director of Diaceutics PLC, he joined the company in 2006 and serves as Chief Executive Officer since January 1, 2024 and is responsible for the innovation strategy for...

Leadership Team

NamePositionTenureCompensationOwnership
Peter Keeling
Founder & Executive Chairmanless than a yearUK£310.99k18.65%
€ 21.9m
Ryan Keeling
CEO & Directorless than a yearUK£282.49k3.54%
€ 4.2m
Nicholas Roberts
CFO & Director2.7yrsUK£193.05k0.050%
€ 58.7k
Ken Ruppel
Vice President of Scientific & Medical Servicesless than a yearno datano data
Gillian Shaw
General Counsel2.8yrsno datano data
Amie McNiece
Vice President of Marketingless than a yearno datano data
Marianna Sciortino
Interim VP of Salesless than a yearno datano data
Sandra Blake
Chief People Officerless than a yearno datano data
Jordan Clark
Chief Data Officer? & Executive Directorless than a yearno data0.83%
€ 979.8k
Susanne Munksted
Chief Precision Medicine Officer5.8yrsno data0.30%
€ 347.3k
Jillian Beggs
Chief Commercial Officer1.8yrsno datano data
Madeline Brown
VP & Chief of Staffless than a yearno datano data

0.8yrs

Average Tenure

42yo

Average Age

Experienced Management: 7DC's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Peter Keeling
Founder & Executive Chairmanless than a yearUK£310.99k18.65%
€ 21.9m
Ryan Keeling
CEO & Directorno dataUK£282.49k3.54%
€ 4.2m
Nicholas Roberts
CFO & Director2.7yrsUK£193.05k0.050%
€ 58.7k
Jordan Clark
Chief Data Officer? & Executive Directorless than a yearno data0.83%
€ 979.8k
Graham Paterson
Senior Independent Director1.1yrsUK£15.00k0.087%
€ 102.2k
Cheryl Macdiarmid
Non-Executive Directorless than a yearno datano data

0.08yrs

Average Tenure

47.5yo

Average Age

Experienced Board: 7DC's board of directors are not considered experienced ( 0.1 years average tenure), which suggests a new board.